ANTIBODY-DRUG CONJUGATES
Clinical trials for ANTIBODY-DRUG CONJUGATES explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-DRUG CONJUGATES trials appear
Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough ovarian cancer when other treatments fail
Disease control Not yet recruitingThis study is testing a drug called sacituzumab for a specific, hard-to-treat type of ovarian cancer (clear cell carcinoma). It is for patients whose cancer has started growing again after treatment with immunotherapy. The goal is to see if this new drug can shrink tumors and con…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New two-drug attack on spreading colon cancer enters testing
Disease control Not yet recruitingThis study is testing if a new drug called SHR-1811, when combined with an existing drug (bevacizumab), can help control advanced colorectal cancer that has spread and worsened after standard first treatment. It will involve about 80 adults whose cancer has a certain level of a p…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC